| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/12/2005 | WO2005002572A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases |
| 05/12/2005 | WO2004105757A3 Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy |
| 05/12/2005 | WO2004096802A3 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
| 05/12/2005 | WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 05/12/2005 | US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate |
| 05/12/2005 | US20050101769 CD40-interacting and TRAF-interacting proteins |
| 05/12/2005 | US20050101662 Such as coumarin, dicoumarol, 7-hydroxycoumarin (umbelliferone), 6,7- dihydroxycoumarin (exculetin), 3,6,7 trihydroxycoumarin, warfarin, or warfarin sodium; cancer, Alzheimer's disease, gout, atherosclerosis, restenosis |
| 05/12/2005 | US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents |
| 05/12/2005 | US20050101658 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 05/12/2005 | US20050101652 New salt hydrates |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | US20050101637 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 05/12/2005 | US20050101636 PPAR-activating compound and pharmaceutical composition comprising the compound |
| 05/12/2005 | US20050101635 Delivering to an external portion of the body passageway of a patient in need of a therapeutically effective amount of an antihistamine or decongestant to treat inflammatory diseases |
| 05/12/2005 | US20050101634 Bis(5-aeyl-2-pyridyl) derivatives |
| 05/12/2005 | US20050101615 Pyridopyrimidine or naphthyridine derivative |
| 05/12/2005 | US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases |
| 05/12/2005 | US20050101610 Antiischemic agents; brain disorders; cardiovascular disorders; for the alleviation or treatment of symptoms due to neurodegenerative diseases and symptoms derived from diabetes, arteriosclerosis and inflammatory diseases ; for example, N-tert-butoxycarbonyl-4-[4-(4-fluorophenoxy)phenyl]-4-piperidinol |
| 05/12/2005 | US20050101609 Quinazoline derivatives as kinase inhibitors |
| 05/12/2005 | US20050101593 Phosphoric acid salt of an integrin receptor antagonist |
| 05/12/2005 | US20050101585 Cannabis-1 (CB1) receptor antagonists; for treatment/inhibiton of drug induced obesity in juveniles/adolescents |
| 05/12/2005 | US20050101584 Selective estrogen receptor-beta ligands |
| 05/12/2005 | US20050101575 Vitamin d3 derivatives and remedies using the same |
| 05/12/2005 | US20050101567 Using a sulfonamide containing compound |
| 05/12/2005 | US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders |
| 05/12/2005 | US20050101539 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 05/12/2005 | US20050101537 Use of exendins and agonists thereof for lowering plasma lipid |
| 05/12/2005 | US20050101536 Modulation of angiogenesis |
| 05/12/2005 | US20050101529 Protein modification and maintenance molecules |
| 05/12/2005 | US20050101528 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 05/12/2005 | US20050101527 Method for treating the central nervous system by administration of igf structural analogs |
| 05/12/2005 | US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents |
| 05/12/2005 | US20050101522 Antihyperplastic agents; antitumor agents; side effect reduction |
| 05/12/2005 | US20050101521 Bind as ligands to human peroxisome proliferator activated receptor to activate receptor and thereby exhibit potent effects of decreasing neutral fat, cholesterol, and blood sugar; for example, 2-[[4-ethoxy-3-[[[4-(2-pyridyloxy)phenyl]carbonylamino]methyl]phenyl]methyl]butyric acid; diabetes treatment |
| 05/12/2005 | US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors |
| 05/12/2005 | US20050100894 Novel mitogen activated kinase |
| 05/12/2005 | US20050100617 Method for improving age-related physiological deficits and increasing longevity |
| 05/12/2005 | US20050100614 Chromium bound to niacin and three compounds from the group consisting of (-) hydroxycitric acid, zinc (particularly zinc methionine), trans-reseveratrol, gymnernic acid, selenium, an anthocyanidin, allicin, and fenugreek. |
| 05/12/2005 | US20050100589 Transdermal administration of ace inhibitors |
| 05/12/2005 | US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells |
| 05/12/2005 | US20050100540 Platelet-activating factor acetylhydrolase |
| 05/12/2005 | US20050100536 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 05/12/2005 | DE69533058T2 Speicherplattenanordnung mit redundanter Speicherung und Verfahren zur inkrementalen Redundanzerzeugung während des Datenschreibens auf die Speicherplattenanordnung Disk array with redundant storage and method for incremental redundancy generation during data write to the disk array |
| 05/12/2005 | CA2544772A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 05/12/2005 | CA2544763A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 05/12/2005 | CA2544377A1 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 05/12/2005 | CA2544310A1 New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof |
| 05/12/2005 | CA2543794A1 Novel multipotent stem cells and use thereof |
| 05/12/2005 | CA2543745A1 Methods of organ regeneration |
| 05/12/2005 | CA2542874A1 Compositions of stabilized dna for coating microprojections |
| 05/11/2005 | EP1529528A1 2-pyrrolidone derivatives and their use in protecting mammalian cells against oxidation stress |
| 05/11/2005 | EP1529114A1 Process for preparing peptides with anti-hypertensive properties |
| 05/11/2005 | EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | EP1529047A2 New purine derivatives |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/11/2005 | EP1528863A1 Cereal based food product comprising dha and/or epa |
| 05/11/2005 | EP1421064B1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives |
| 05/11/2005 | EP1417172A4 Process for the preparation of amorphous form of torsemide |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1370245B1 Method to prepare microparticles containing metoprolol |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1221952B1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 05/11/2005 | EP1154777B1 Medicament for treating hypertension |
| 05/11/2005 | EP1105738B1 Assays for modulating nuclear localisation |
| 05/11/2005 | EP1083931B1 Stabilization of compositions containing ace inhibitors using magnesium oxide |
| 05/11/2005 | CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615357A Process for the manufacture of human mononuclear phagocytic leukocytes |
| 05/11/2005 | CN1615309A Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 05/11/2005 | CN1615307A Process and intermediates for pyridazinone antidiabetic agents |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |
| 05/11/2005 | CN1615296A Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 05/11/2005 | CN1615153A Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 05/11/2005 | CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/11/2005 | CN1615148A Methods and compositions for derepression of IAP-inhibited caspase |
| 05/11/2005 | CN1615144A A composition for treating neurocerebrovascular disorders |
| 05/11/2005 | CN1615137A Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 05/11/2005 | CN1615134A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 05/11/2005 | CN1615133A Crystalline solids of carvedilol and processes for their preparation |
| 05/11/2005 | CN1614028A Dried bacterial powder process containing gamma-linolenic acid |
| 05/11/2005 | CN1613487A Xinshu capsule |
| 05/11/2005 | CN1613468A Medical pillow |
| 05/11/2005 | CN1613444A Efferverscent tablets containing troxerutin and their preparation |
| 05/11/2005 | CN1200946C Process for preparation of N2-(1(S)-carboxy-3-phenylpropyl)-L-lysyl-L-proline |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 05/11/2005 | CN1200720C Ointment for treating burn and its preparing process |
| 05/11/2005 | CN1200715C Adetphos sodium chloride injection and its preparation method |
| 05/11/2005 | CN1200714C Use of diterpenoid triepoxides as anti-proliferative agent |
| 05/11/2005 | CN1200713C New (aminopropyl) methylphosphinic acids |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/11/2005 | CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease |
| 05/11/2005 | CN1200700C Pharmaceutical tramadol salts |
| 05/10/2005 | US6891066 For therapy of cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain |
| 05/10/2005 | US6891063 Salts with pharmaceutically acceptable organic bases, selected from ethylenediamine, ethanolamine, diethanolamine, lysine, benzyltrimethylammonium hydroxide and tetramethylammonium hydroxide; antiinflammatory agents, wound healing agents |
| 05/10/2005 | US6890959 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |